ONCAlert | Upfront Therapy for mRCC
News
Romiplostim Receives FDA Approval for Pediatric ITP
8:44 PM, Fri December 14, 2018
BiTE Antibodies Show Promise in Myeloma and AML
5:40 PM, Fri December 14, 2018
Pivotal Phase III Trial Initiated to Investigate Role of Cabozantinib in Advanced HCC
5:22 PM, Fri December 14, 2018
Voorhees Highlights Encouraging Findings With Daratumumab Plus RVd in Myeloma
4:43 PM, Fri December 14, 2018
Every Patient With a GI Tumor Should Have MSI Testing Done, Saif Says
3:15 PM, Fri December 14, 2018
Keiser Compares the Use of 2 Agents for Patients With Metastatic CRC
2:47 PM, Fri December 14, 2018
Shift in MCL Induction Therapy Has Led to Improvement in Event-Free Survival in Real World
6:03 PM, Thu December 13, 2018
High MRD-Negative Status Seen With Venetoclax Plus Rituximab Combination in CLL
4:33 PM, Thu December 13, 2018
